Press Release

  View printer-friendly version

« Back

West Announces Participation in Upcoming November Investor Conferences

EXTON, Pa., Nov. 1, 2018 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced that its Management Team will present an overview of the Company's business at two investor conferences in November. Management will present at the Stephens Investment Conference in New York, New York on Wednesday, November 7, 2018, and the Jefferies 2018 London Healthcare Conference in London, United Kingdom on Thursday, November 15, 2018. 

(PRNewsfoto/West Pharmaceutical Services, I)

A live audio webcast and the presentation will be accessible from the Company's website at

About West
West Pharmaceutical Services, Inc. is a leading manufacturer of packaging components and delivery systems for injectable drugs and healthcare products. Working by the side of its customers from concept to patient, West creates products that promote the efficiency, reliability and safety of the world's pharmaceutical drug supply. West is headquartered in Exton, Pennsylvania, and supports its customers from locations in North and South America, Europe, Asia and Australia. West's 2017 net sales of $1.6 billion reflect the daily use of approximately 112 million of its components and devices, which are designed to improve the delivery of healthcare to patients around the world.

Trademarks and registered trademarks are the property of West Pharmaceutical Services, Inc. in the United States and other jurisdictions, unless noted otherwise.

Investor Contact:

Media Contact:

Quintin Lai

Emily Denney

Vice President, Investor Relations

Vice President, Global Communications




Cision View original content to download multimedia:

SOURCE West Pharmaceutical Services, Inc.